Access to drugs: a failure of pharma?
Many people around the world are either unable to afford the drugs they need, or their conditions have not been addressed by pharma R&D. Sarah Houlton investigates
The availability of modern medicines has driven dramatic improvements in human health, which are enjoyed by many of us living comfortably in developed countries. Yet there are many patients for whom treatment options are limited, whether that is because there are no drugs that treat their disease, or they cannot get access to those that do exist. In both cases, these are particular problems in the developing world. What is being done to address these concerns?